Showing results (1-10 of 516) with videos related to
Sort By:
Pageof 52
Expert Opinion on Therapeutic Targets|June 12, 2018
Triggering receptor expressed on myeloid cells 2 (TREM2): a potential therapeutic target for Alzheimer disease?Yuetiva Deming, Zeran Li, Bruno A Benitez, et al.Neurobiology of Disease|January 11, 2021
Quantitative endophenotypes as an alternative approach to understanding genetic risk in neurodegenerative diseasesFabiana H G Farias, Bruno A Benitez, Carlos CruchagaMethods in Molecular Biology (Clifton, N.J.)|August 4, 2015
Pooled-DNA Sequencing for Elucidating New Genomic Risk Factors, Rare Variants Underlying Alzheimer's DiseaseSheng Chih Jin, Bruno A Benitez, Yuetiva Deming, et al.Neurobiology of Aging|February 9, 2013
TREM2 is associated with the risk of Alzheimer's disease in Spanish populationBruno A Benitez, Breanna Cooper, Pau Pastor, et al.Neurobiology of Aging|November 26, 2015
Variants in GBA, SNCA, and MAPT influence Parkinson disease risk, age at onset, and progressionAlbert A Davis, Kristin M Andruska, Bruno A Benitez, et al.Alzheimer'S Research & Therapy|August 22, 2012
Pooled-DNA sequencing identifies novel causative variants in PSEN1, GRN and MAPT in a clinical early-onset and familial Alzheimer's disease Ibero-American cohortSheng Chih Jin, Pau Pastor, Breanna Cooper, et al.Experimental Eye Research|January 14, 2014
Genetic high throughput screening in Retinitis Pigmentosa based on high resolution melting (HRM) analysisAnder Anasagasti, Olatz Barandika, Cristina Irigoyen, et al.Acta Neuropathologica Communications|November 28, 2015
Clinically early-stage CSPα mutation carrier exhibits remarkable terminal stage neuronal pathology with minimal evidence of synaptic lossBruno A Benitez, Nigel J Cairns, Robert E Schmidt, et al.Neurobiology of Aging|May 2, 2017
TMEM230 in Parkinson's diseaseLaura Ibanez, Umber Dube, John Budde, et al.Med (New York, N.Y.)|May 19, 2022
Integrating functional genomics with genetics to understand the biology of ALS and FTDCarlos CruchagaPageof 52